🇺🇸 FDA
Pipeline program

DEXAMETHASONE, CAPECITABINE , OXALIPLATIN , FLUOROURACIL , FOLINIC ACID, METOCLOPRAMIDE, ONDANSETRON

IJB-SHAPERS-ODN-013

Phase 3 small_molecule active

Quick answer

DEXAMETHASONE, CAPECITABINE , OXALIPLATIN , FLUOROURACIL , FOLINIC ACID, METOCLOPRAMIDE, ONDANSETRON for locally advanced rectal cancer is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
locally advanced rectal cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials